NASDAQ
No price data available for this timeframe.
Lineage Cell Therapeutics, Inc. (LCTX) has a revenue compound annual growth rate of 79.88% over 5 years and 19.10% over 10 years. Revenue CAGR shows the compound annual growth rate of a company's total sales, indicating the pace of top-line expansion.